Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer.
Zhang B, Li Y, Wu Q, Xie L, Barwick B, Fu C, Li X, Wu D, Xia S, Chen J, Qian WP, Yang L, Osunkoya AO, Boise L, Vertino PM, Zhao Y, Li M, Chen HR, Kowalski J, Kucuk O, Zhou W, Dong JT.
Zhang B, et al. Among authors: chen j, chen hr.
Nat Commun. 2021 Mar 17;12(1):1714. doi: 10.1038/s41467-021-21976-w.
Nat Commun. 2021.
PMID: 33731701
Free PMC article.